Qualitative or quantitative defects of dysferlin

Qualitative or quantitative defects of dysferlin (Orphanet code 207073) is a grouping term that encompasses a spectrum of muscular dystrophies caused by mutations in the DYSF gene, which encodes the protein dysferlin. Dysferlin plays a critical role in muscle membrane repair, and its deficiency or dysfunction leads to progressive muscle degeneration. The major clinical presentations associated with dysferlin defects include Miyoshi myopathy (distal myopathy predominantly affecting the calf muscles), limb-girdle muscular dystrophy type R2 (formerly LGMD2B, primarily affecting proximal muscles of the hips and shoulders), and distal myopathy with anterior tibial onset. These conditions are collectively referred to as dysferlinopathies. Patients typically present in late adolescence or early adulthood with progressive muscle weakness and wasting. In Miyoshi myopathy, early symptoms often include difficulty standing on tiptoes and weakness in the calves, while in LGMD R2, patients experience difficulty climbing stairs, rising from chairs, and raising their arms. Serum creatine kinase (CK) levels are characteristically markedly elevated, often 10 to 100 times normal values, sometimes even before clinical symptoms become apparent. Muscle biopsy typically shows dystrophic changes with absent or markedly reduced dysferlin on immunostaining or Western blot analysis. There is currently no cure or disease-specific treatment for dysferlinopathies. Management is supportive and includes physical therapy to maintain mobility and function, orthopedic interventions as needed, and monitoring for cardiac and respiratory complications, although these are less common than in some other muscular dystrophies. Excessive exercise may be detrimental and is generally discouraged. Research into gene therapy, protein replacement, and other molecular approaches is ongoing. Genetic counseling is recommended for affected individuals and their families.

Common questions about Qualitative or quantitative defects of dysferlin